Comparative Pharmacology
Head-to-head clinical analysis: METHADONE HYDROCHLORIDE INTENSOL versus METHADONE MOUD.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADONE HYDROCHLORIDE INTENSOL versus METHADONE MOUD.
METHADONE HYDROCHLORIDE INTENSOL vs Methadone (MOUD)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist. It also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake. Its long duration of action is due to high protein binding and tissue sequestration.
Methadone is a mu-opioid receptor agonist with high affinity. It also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and maintenance effects.
Oral: 2.5-10 mg every 8-12 hours; titrate slowly. Typical adult dose: 5-10 mg PO every 8-12 hours.
Initial: 20-30 mg orally once daily, titrated to effect. Maintenance: 10-120 mg orally once daily. Route: oral (tablet, liquid). Frequency: once daily.
None Documented
None Documented
Terminal elimination half-life ranges from 15 to 60 hours (mean ~24-36 hours). The long half-life allows for once-daily dosing in maintenance therapy but risk of accumulation and delayed toxicity during initiation.
Terminal elimination half-life: 24-36 hours following single dose; 13-50 hours with chronic dosing (due to tissue redistribution). Context: prolonged half-life supports once-daily dosing for opioid use disorder but requires careful titration to avoid accumulation.
Methadone is primarily eliminated via feces (about 50-60%) and urine (about 20-30%), with approximately 10% as unchanged drug in urine. Biliary excretion contributes to fecal elimination.
Primarily renal (20-40% as unchanged drug, with urine pH-dependent elimination; 50% as metabolites including EDDP and EMDP). Biliary/fecal excretion accounts for approximately 10-15%.
Category D/X
Category A/B
Opioid Agonist
Opioid Agonist